Inactive Instrument

Dimed S.A. Distribuidora de Medicamentos Stock price Sao Paulo

Equities

PNVL4

BRPNVLACNPR6

Drug Retailers

Sales 2024 * 5.08B 1.02B Sales 2025 * 5.76B 1.15B Capitalization 1.8B 359M
Net income 2024 * 173M 34.55M Net income 2025 * 243M 48.53M EV / Sales 2024 * 0.4 x
Net Debt 2024 * 255M 50.93M Net Debt 2025 * 190M 37.85M EV / Sales 2025 * 0.35 x
P/E ratio 2024 *
10.5 x
P/E ratio 2025 *
5.73 x
Employees 10,284
Yield 2024 *
3.8%
Yield 2025 *
4.96%
Free-Float 55.61%
More Fundamentals * Assessed data
Dynamic Chart
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dimed S.A. Distribuidora De Medicamentos Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Dimed S.A. Distribuidora de Medicamentos's Equity Buyback announced on August 13, 2020, has expired with 1,700,000 shares, representing 1.19% for BRL 36.10 million. CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tranche Update on Dimed S.A. Distribuidora de Medicamentos's Equity Buyback Plan announced on August 13, 2020. CI
Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Dimed S.A. Distribuidora de Medicamentos's Equity Buyback announced on August 13, 2020, has expired. CI
More news
Managers TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 46 09-12-31
Chairman 78 67-02-28
Members of the board TitleAgeSince
Chairman 78 67-02-28
Director/Board Member 69 08-04-27
Director/Board Member 51 20-07-16
More insiders
Dimed SA Distribuidora de Medicamentos, formerly Panvel SA Drogarias e Farmacias, is a Brazil-based company principally engaged in the sale of drugs. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. It organizes its business into two main segments: Medicine and Perfumery. The Company provides retail and wholesale distribution. The Company owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Dimed S.A. Distribuidora de Medicamentos
  4. Stock Dimed S.A. Distribuidora de Medicamentos - Sao Paulo